Together we will beat cancer

Donate

Personalised blood test could help predict which lung cancers might return

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.

Read More

Reduction in women screened for breast cancer between 2020 and 2021, NHS report finds

A new report by NHS Digital reveals how breast screening services were impacted during the COVID-19 pandemic.

Read More

No link between breast pain alone and cancer diagnosis, study finds

Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms.

Read More

Aromatase inhibitors cut breast cancer recurrence in younger patients

A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.

Read More

Immunotherapy treatment fast tracked to treat lung cancer patients in England

Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England.

Read More

Atlantic rowing trio smash world record and raise thousands for cancer charities

A British woman with an incurable cancer has broken the world record for rowing across the Atlantic, raising thousands for Cancer Research UK.

Read More

Cancer Research UK publishes gender and ethnicity pay gap reports

The charity publishes its gender and ethnicity pay gap reports.

Read More

New breast and lung cancer treatments approved in Scotland

3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for use on the NHS in Scotland, including 2 breast cancer treatments and 1 for lung cancer.

Read More

New lung cancer treatment combo approved on NHS in England

A new treatment for some people with a type of non small cell lung cancer (NSCLC) will now be routinely available on the NHS in England, following its approval by the National Institute of Health and Care Excellence (NICE).

Read More

Immunotherapy approved for some people with advanced melanoma in England

The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer.

Read More